Show Me CKDintercept Initiative: A Collective Impact Approach to Improve Population Health in Missouri

Mayo Clinic proceedings. Innovations, quality & outcomes Pub Date : 2024-01-12 DOI:10.1016/j.mayocpiqo.2023.12.004

Katelyn Laue MPH , Megan Schultz MPH , Elizabeth Talbot-Montgomery BS , Alexandra Garrick MSEd , Anuja Java MD , Christine Corbett DNP , Dana M. Lammert MA , JoAnna Rogers BA , Kathleen Davis BS , Kunal Malhotra MD , Marie Philipneri MD, PhD , Mary Ann Kimbel RN , Reem A. Mustafa MD, MPH, PhD , Valerie Hardesty MPH

{"title":"Show Me CKDintercept Initiative: A Collective Impact Approach to Improve Population Health in Missouri","authors":"Katelyn Laue MPH , Megan Schultz MPH , Elizabeth Talbot-Montgomery BS , Alexandra Garrick MSEd , Anuja Java MD , Christine Corbett DNP , Dana M. Lammert MA , JoAnna Rogers BA , Kathleen Davis BS , Kunal Malhotra MD , Marie Philipneri MD, PhD , Mary Ann Kimbel RN , Reem A. Mustafa MD, MPH, PhD , Valerie Hardesty MPH","doi":"10.1016/j.mayocpiqo.2023.12.004","DOIUrl":null,"url":null,"abstract":"<div><p>Ninety percent of people with chronic kidney disease (CKD) remain undiagnosed, most people at risk do not receive guideline-concordant testing, and disparities of care and outcomes exist across all stages of the disease. To improve CKD diagnosis and management across primary care, the National Kidney Foundation launched a collective impact (CI) initiative known as Show Me CKDintercept. The initiative was implemented in Missouri, USA from January 2021 to June 2022, using a data strategy, stakeholder engagement and relationship mapping, learning in action working groups (LAWG), and a virtual leadership summit. The Reach, Effectiveness, Adoption, Implementation, and Maintenance framework was used to evaluate success. The initiative united 159 stakeholders from 81 organizations (Reach) to create an urgency for change and engage new CKD champions (Effectiveness). The adoption resulted in 53% of participants committed to advancing the roadmap (Adoption). Short-term results reported success in laying a foundation for CI across Missouri. The long-term success of the CI initiative in addressing the public health burden of kidney disease remains to be determined. The project reported the potential use of a CI initiative to build leadership consensus to drive measurable public health improvements nationwide.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000796/pdfft?md5=3379d449c38ed551f518b28186bbcf8c&pid=1-s2.0-S2542454823000796-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mayo Clinic proceedings. Innovations, quality & outcomes","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2542454823000796","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Ninety percent of people with chronic kidney disease (CKD) remain undiagnosed, most people at risk do not receive guideline-concordant testing, and disparities of care and outcomes exist across all stages of the disease. To improve CKD diagnosis and management across primary care, the National Kidney Foundation launched a collective impact (CI) initiative known as Show Me CKDintercept. The initiative was implemented in Missouri, USA from January 2021 to June 2022, using a data strategy, stakeholder engagement and relationship mapping, learning in action working groups (LAWG), and a virtual leadership summit. The Reach, Effectiveness, Adoption, Implementation, and Maintenance framework was used to evaluate success. The initiative united 159 stakeholders from 81 organizations (Reach) to create an urgency for change and engage new CKD champions (Effectiveness). The adoption resulted in 53% of participants committed to advancing the roadmap (Adoption). Short-term results reported success in laying a foundation for CI across Missouri. The long-term success of the CI initiative in addressing the public health burden of kidney disease remains to be determined. The project reported the potential use of a CI initiative to build leadership consensus to drive measurable public health improvements nationwide.

查看原文本刊更多论文

Show Me CKDintercept Initiative：改善密苏里州人口健康的集体影响方法

90%的慢性肾脏病（CKD）患者仍未得到诊断，大多数高危人群没有接受与指南一致的检测，而且在疾病的各个阶段都存在护理和治疗效果的差异。为了改善基层医疗机构的 CKD 诊断和管理，全美肾脏基金会发起了一项名为 Show Me CKDintercept 的集体影响（CI）倡议。该倡议于 2021 年 1 月至 2022 年 6 月在美国密苏里州实施，采用了数据战略、利益相关者参与和关系图、行动中学习工作组 (LAWG) 和虚拟领导峰会。评估成功与否采用了 "覆盖面、有效性、采用、实施和维护 "框架。该倡议将来自 81 个组织的 159 名利益相关者联合起来（"覆盖面"），创造了变革的紧迫感，并吸引了新的 CKD 倡导者（"有效性"）。53% 的参与者承诺推进路线图（采用）。短期结果表明，成功地为密苏里州的 CI 奠定了基础。CI 计划在解决肾脏疾病公共卫生负担方面的长期成功仍有待确定。该项目报告称，CI 计划可用于建立领导共识，以推动全国范围内可衡量的公共卫生改善。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Mayo Clinic proceedings. Innovations, quality & outcomes Surgery, Critical Care and Intensive Care Medicine, Public Health and Health Policy

自引率

0.00%

发文量

审稿时长

49 days